These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 6454856)

  • 1. [Hormone treatment of metastasizing breast carcinoma].
    Navarra S; Melita P; Di Mauro S; Calbo L; Belnome N
    Minerva Chir; 1981 Jun; 36(12):853-60. PubMed ID: 6454856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Value of hormone therapy in metastasizing breast cancer].
    Samonigg H
    Wien Med Wochenschr; 1985 Dec; 135(23-24):602-7. PubMed ID: 2937208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Endocrine treatment of gynecologic neoplasms].
    Maass H
    Fortschr Med; 1980 Oct; 98(40):1551-3. PubMed ID: 7461551
    [No Abstract]   [Full Text] [Related]  

  • 4. [Which hormone therapy should be used in advanced breast carcinoma in males?].
    Lönning PE; Wiedemann G; Kvinnsland S; Lundgren S
    Dtsch Med Wochenschr; 1988 Sep; 113(35):1358-61. PubMed ID: 2970379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medroxyprogesterone acetate versus tamoxifen in the therapy of advanced breast cancer.
    Lorenz I; Mechl Z
    Neoplasma; 1985; 32(1):119-24. PubMed ID: 3157070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormone therapy in advanced breast cancer: high dose medroxyprogesterone acetate (MAP) vs tamoxifen (TMX). Preliminary results.
    Pannuti F; Martoni A; Fruet F; Strocchi E; Di Marco AR
    Eur J Cancer (1965); 1980; Suppl 1():93-8. PubMed ID: 6459237
    [No Abstract]   [Full Text] [Related]  

  • 7. [High-dose gestagen therapy in breast cancer].
    Beaufort F; Fereberger W
    Wien Med Wochenschr; 1983 Apr; 133(7):169-73. PubMed ID: 6223450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Endocrine therapy of breast cancer].
    Jonat W; Maass H
    Zentralbl Gynakol; 1987; 109(10):617-27. PubMed ID: 2956805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The importance of hormone receptor analysis for diagnosis and therapy of gynecologic malignancies].
    Gitsch E; Salzer H
    Wien Klin Wochenschr; 1983 May; 95(11):385-8. PubMed ID: 6310902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Breast cancer and hormone therapy].
    Izuo M
    Gan To Kagaku Ryoho; 1987 Oct; 14(10):2830-6. PubMed ID: 2959203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination therapy with progestins and tamoxifen in advanced breast cancer: A preliminary report.
    Trodella L; Ausilli-Cefaro GP; Turriziani A; Saccheri S; Venturo I; Minotti G
    Am J Clin Oncol; 1982 Oct; 5(5):495-9. PubMed ID: 6217741
    [No Abstract]   [Full Text] [Related]  

  • 12. [Trial hormone therapy of advanced breast cancers with calusterone. Preliminary study of 41 cases].
    Brule G; Chauvergne J; Clavel B; Gary-Bobo J; Gurrin J; Klein T; Pommatau E
    Sem Hop; 1974 Dec 8-14; 50(50-51):3099-105. PubMed ID: 4377318
    [No Abstract]   [Full Text] [Related]  

  • 13. [Endocrine therapy of breast cancer].
    Bassalyk LS; Murav'eva NI; Smirnova KD; Kuz'mina ZV
    Sov Med; 1981; (12):54-9. PubMed ID: 7038903
    [No Abstract]   [Full Text] [Related]  

  • 14. [Megestrol acetate as hormone therapy in oncology].
    Berstein LM
    Vopr Onkol; 1998; 44(2):142-8. PubMed ID: 9615815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New role of endocrine therapy in breast cancer.
    Kennedy BJ
    Int J Radiat Oncol Biol Phys; 1978; 4(5-6):469-72. PubMed ID: 689948
    [No Abstract]   [Full Text] [Related]  

  • 16. Expression of prostate-specific antigen (PSA) correlates with poor response to tamoxifen therapy in recurrent breast cancer.
    Foekens JA; Diamandis EP; Yu H; Look MP; Meijer-van Gelder ME; van Putten WL; Klijn JG
    Br J Cancer; 1999 Feb; 79(5-6):888-94. PubMed ID: 10070886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [High-dose gestagen therapy with medroxyprogesterone acetate in metastasizing breast carcinoma].
    Bastert G; Michel RT
    Med Welt; 1983 Mar; 34(12):378-82. PubMed ID: 6222235
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hormonreceptors in the therapy concept of breast cancer (author's transl)].
    Jonat W; Maass H
    Arch Geschwulstforsch; 1981; 51(7):637-41. PubMed ID: 7337546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hormone therapy in metastasized breast cancer. Criteria for establishing indications and implementing high-dose medroxyprogesterone acetate therapy].
    Possinger K; Wagner H; Langecker P; Schmid L; Willich S; Wilmanns W
    Fortschr Med; 1987 Jul; 105(22):421-4. PubMed ID: 2958397
    [No Abstract]   [Full Text] [Related]  

  • 20. [Progestational agents and bone metastasis in breast cancer].
    Leriche N; Bonneterre J
    Bull Cancer; 1997 Sep; 84(9):891-4. PubMed ID: 9435812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.